Search Results

0 results for 'Sanofi US Services Inc.'

You can use to get even better search results
July 29, 2024 | Connecticut Law Tribune

Hundreds of Plaintiffs Deploy Litigation Strategy in Zantac Suits

"Juries can be fickle, and if you have to try nine cases nine times, you may get nine different results," Peter Bowman, a personal injury lawyer for BBB Attorneys, said.
3 minute read
April 25, 2024 | Texas Lawyer

Longtime Paris-Based McDermott Partner Joins Rimon in Texas

"Texas is the place to be," said Nicolas Lafont, the latest Rimon lateral hire to cite the firm's rate flexibility as a key reason for his move.
3 minute read
April 25, 2024 | National Law Journal

Longtime France-Based McDermott Partner Joins Rimon in Texas

"Texas is the place to be," said Nicolas Lafont, the latest Rimon lateral hire to cite the firm's rate flexibility as a key reason for his move.
3 minute read
April 25, 2024 | New Jersey Law Journal

As Eli Lilly's Insulin Pricing Settlement Unravels, Lawyers Vow to Push Ahead

Lawyers touting a $500 million settlement over insulin pricing are back at the drawing board after a judge refused to certify their class.
5 minute read
April 23, 2024 | Connecticut Law Tribune

Civil RICO Suit Accuses Big Pharma and Benefit Managers of Insulin Price-Fixing

"Rather than working to lower insulin and other Type 2 diabetes medication prices, major [pharmacy benefit managers] and manufacturers use their dominant market positions to drastically increase the price of these necessary, life-saving medications, generating billions of dollars in illicit profits," co-lead counsel for the plaintiff claimed in a joint statement.
4 minute read
April 11, 2024 | The American Lawyer

Boosted by Litigation, IP and Regulatory Work, Revenue Ticks Up at Wilson Sonsini

Demand varied across the firm's corporate practices, but some areas, such as environmental work, privacy and cybersecurity, were busy.
6 minute read
February 21, 2024 | Law.com

Treatment of Antibody Claims In the U.S. After 'Amgen v. Sanofi'

The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.
8 minute read
February 09, 2024 | New Jersey Law Journal

Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis

"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.
7 minute read
February 06, 2024 | National Law Journal

Arnold & Porter Sees Revenue and Profits Jump, With PEP Rising 15% to $1.6M

The environment for counsel on government-facing issues was "quite strong" last year, driving demand across the firm's litigation, transaction and regulatory practices, said chairman Richard Alexander.
3 minute read

Resources

  • Document Review Challenges: Strategies for Law Firm Litigation Professionals in 2024

    Brought to you by Integreon

    Download Now

  • From Burnout to Breakthrough: How Technology Enhances Legal Wellness

    Brought to you by Nuix

    Download Now

  • The 2024 Benchmark of Ethical Culture Report

    Brought to you by LRN

    Download Now

  • State Lawmakers Targeting Plastic Pollution in 2024

    Brought to you by LexisNexis®

    Download Now